Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Adi Diab

17PUBLICATIONS

256CO-AUTHORS

Tumour immunologyCancer geneticsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|Mar 06, 2025

Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301).

Adi Diab, Paolo A Ascierto, Michele Maio

|Oct 25, 2024

Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers: Usability and Acceptability Study.

Maria A Lopez-Olivo, Maria E Suarez-Almazor, Gabrielle F Duhon

|Aug 31, 2023

Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results.

Adi Diab, Helen Gogas, Shahneen Sandhu

|Jun 16, 2023

Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events.

Faisal Fa'ak, Maryam Buni, Adewunmi Falohun

|May 16, 2023

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.

Talal El Zarif, Amin H Nassar, Elio Adib

|Feb 24, 2023

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial.

A S Feils, A K Erbe, J Birstler

Pageof 3

Frequent Collaborators

4 joint publications

Jennifer A Wargo

4 joint publications

Hussein Tawbi

3 joint publications

Vancheswaran Gopalakrishnan

3 joint publications

Michael T Tetzlaff

3 joint publications

P Andrew Futreal

3 joint publications

Alexander J Lazar

3 joint publications

Nadim J Ajami

3 joint publications

Isabella C Glitza

3 joint publications

Alexandria P Cogdill

3 joint publications

Courtney W Hudgens

Frequent Collaborators

4 joint publications

Jennifer A Wargo

4 joint publications

Hussein Tawbi

3 joint publications

Vancheswaran Gopalakrishnan

3 joint publications

Michael T Tetzlaff

Top Related Videos

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on : Nov 11, 2016

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on : Oct 16, 2018

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on : Apr 22, 2019

See more related videos

Top Related Videos

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on : Nov 11, 2016

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on : Oct 16, 2018

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on : Apr 22, 2019

See more related videos